Combined ibrutinib and venetoclax for treatment of patients with ibrutinib-resistant or double-refractory chronic lymphocytic leukaemia

Paul J. Hampel, Kari G. Rabe, Timothy G. Call, Wei Ding, Jose F. Leis, Saad S. Kenderian, Eli Muchtar, Yucai Wang, Amber B. Koehler, Ricardo Parrondo, Susan M. Schwager, Min Shi, Esteban Braggio, Susan L. Slager, Neil E. Kay, Sameer A. Parikh

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Combined ibrutinib and venetoclax for treatment of patients with ibrutinib-resistant or double-refractory chronic lymphocytic leukaemia'. Together they form a unique fingerprint.

Medicine & Life Sciences